▶ 調査レポート

肺塞栓症治療薬の世界市場規模・現状・予測(2021-2027)

• 英文タイトル:Global Pulmonary Embolism Therapeutics Market Size, Status and Forecast 2021-2027
• レポートコード:QFJ1-5974
• 出版社/出版日:QYResearch / 2021年6月※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、肺塞栓症治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(経口、非経口)、用途別市場規模(大人用、子供用)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・肺塞栓症治療薬の市場動向
・企業の競争状況、市場シェア
・肺塞栓症治療薬の種類別市場規模と予測2016-2027(経口、非経口)
・肺塞栓症治療薬の用途別市場規模と予測2016-2027(大人用、子供用)
・肺塞栓症治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・肺塞栓症治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・肺塞栓症治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・肺塞栓症治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・肺塞栓症治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Boehringer Ingelheim International、Bristol-Myers Squibb、Daiichi Sankyo、F. Hoffmann-La Roche、Johnson & Johnson)
・結論

Lifestyle associated factors such as smoking, overweight, old-age pregnancy, and excessive use of estrogen supplements are some of the major causes of pulmonary embolism.

Market Analysis and Insights: Global Pulmonary Embolism Therapeutics Market
The global Pulmonary Embolism Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pulmonary Embolism Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pulmonary Embolism Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pulmonary Embolism Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pulmonary Embolism Therapeutics market.

Global Pulmonary Embolism Therapeutics Scope and Market Size
Pulmonary Embolism Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Embolism Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Parenteral

Segment by Application
Adult
Child

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim International
Bristol-Myers Squibb
Daiichi Sankyo
F. Hoffmann-La Roche
Johnson & Johnson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pulmonary Embolism Therapeutics Market Perspective (2016-2027)
2.2 Pulmonary Embolism Therapeutics Growth Trends by Regions
2.2.1 Pulmonary Embolism Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pulmonary Embolism Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Pulmonary Embolism Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Pulmonary Embolism Therapeutics Industry Dynamic
2.3.1 Pulmonary Embolism Therapeutics Market Trends
2.3.2 Pulmonary Embolism Therapeutics Market Drivers
2.3.3 Pulmonary Embolism Therapeutics Market Challenges
2.3.4 Pulmonary Embolism Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue
3.1.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Pulmonary Embolism Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Pulmonary Embolism Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Embolism Therapeutics Revenue
3.4 Global Pulmonary Embolism Therapeutics Market Concentration Ratio
3.4.1 Global Pulmonary Embolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Embolism Therapeutics Revenue in 2020
3.5 Pulmonary Embolism Therapeutics Key Players Head office and Area Served
3.6 Key Players Pulmonary Embolism Therapeutics Product Solution and Service
3.7 Date of Enter into Pulmonary Embolism Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pulmonary Embolism Therapeutics Breakdown Data by Type
4.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2022-2027)

5 Pulmonary Embolism Therapeutics Breakdown Data by Application
5.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pulmonary Embolism Therapeutics Market Size (2016-2027)
6.2 North America Pulmonary Embolism Therapeutics Market Size by Type
6.2.1 North America Pulmonary Embolism Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Pulmonary Embolism Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Pulmonary Embolism Therapeutics Market Size by Type (2016-2027)
6.3 North America Pulmonary Embolism Therapeutics Market Size by Application
6.3.1 North America Pulmonary Embolism Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Pulmonary Embolism Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Pulmonary Embolism Therapeutics Market Size by Application (2016-2027)
6.4 North America Pulmonary Embolism Therapeutics Market Size by Country
6.4.1 North America Pulmonary Embolism Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Pulmonary Embolism Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pulmonary Embolism Therapeutics Market Size (2016-2027)
7.2 Europe Pulmonary Embolism Therapeutics Market Size by Type
7.2.1 Europe Pulmonary Embolism Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Pulmonary Embolism Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Pulmonary Embolism Therapeutics Market Size by Type (2016-2027)
7.3 Europe Pulmonary Embolism Therapeutics Market Size by Application
7.3.1 Europe Pulmonary Embolism Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Pulmonary Embolism Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Pulmonary Embolism Therapeutics Market Size by Application (2016-2027)
7.4 Europe Pulmonary Embolism Therapeutics Market Size by Country
7.4.1 Europe Pulmonary Embolism Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Pulmonary Embolism Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type
8.2.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application
8.3.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region
8.4.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pulmonary Embolism Therapeutics Market Size (2016-2027)
9.2 Latin America Pulmonary Embolism Therapeutics Market Size by Type
9.2.1 Latin America Pulmonary Embolism Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Pulmonary Embolism Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Pulmonary Embolism Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Pulmonary Embolism Therapeutics Market Size by Application
9.3.1 Latin America Pulmonary Embolism Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Pulmonary Embolism Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Pulmonary Embolism Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Pulmonary Embolism Therapeutics Market Size by Country
9.4.1 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type
10.2.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application
10.3.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country
10.4.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Details
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Introduction
11.1.4 Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2016-2021)
11.1.5 Boehringer Ingelheim International Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Introduction
11.3.4 Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2016-2021)
11.3.5 Daiichi Sankyo Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Pulmonary Embolism Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pulmonary Embolism Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pulmonary Embolism Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pulmonary Embolism Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pulmonary Embolism Therapeutics Market Share by Regions (2022-2027)
Table 10. Pulmonary Embolism Therapeutics Market Trends
Table 11. Pulmonary Embolism Therapeutics Market Drivers
Table 12. Pulmonary Embolism Therapeutics Market Challenges
Table 13. Pulmonary Embolism Therapeutics Market Restraints
Table 14. Global Pulmonary Embolism Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pulmonary Embolism Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Embolism Therapeutics as of 2020)
Table 17. Ranking of Global Top Pulmonary Embolism Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pulmonary Embolism Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pulmonary Embolism Therapeutics Product Solution and Service
Table 21. Date of Enter into Pulmonary Embolism Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pulmonary Embolism Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pulmonary Embolism Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pulmonary Embolism Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pulmonary Embolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pulmonary Embolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pulmonary Embolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pulmonary Embolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pulmonary Embolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pulmonary Embolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pulmonary Embolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pulmonary Embolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pulmonary Embolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pulmonary Embolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pulmonary Embolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pulmonary Embolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pulmonary Embolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pulmonary Embolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pulmonary Embolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boehringer Ingelheim International Company Details
Table 62. Boehringer Ingelheim International Business Overview
Table 63. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Product
Table 64. Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Boehringer Ingelheim International Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Product
Table 69. Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Daiichi Sankyo Company Details
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Pulmonary Embolism Therapeutics Product
Table 74. Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Product
Table 79. F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2016-2021) & (US$ Million)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Pulmonary Embolism Therapeutics Product
Table 84. Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Embolism Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Pulmonary Embolism Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Adult Case Studies
Figure 6. Child Case Studies
Figure 7. Pulmonary Embolism Therapeutics Report Years Considered
Figure 8. Global Pulmonary Embolism Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Pulmonary Embolism Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Pulmonary Embolism Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Pulmonary Embolism Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Pulmonary Embolism Therapeutics Market Share by Players in 2020
Figure 13. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Embolism Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Pulmonary Embolism Therapeutics Revenue in 2020
Figure 15. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Pulmonary Embolism Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Pulmonary Embolism Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Pulmonary Embolism Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pulmonary Embolism Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Pulmonary Embolism Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Pulmonary Embolism Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pulmonary Embolism Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Pulmonary Embolism Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Pulmonary Embolism Therapeutics Market Share by Region (2016-2027)
Figure 37. China Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pulmonary Embolism Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Pulmonary Embolism Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Pulmonary Embolism Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pulmonary Embolism Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Pulmonary Embolism Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Pulmonary Embolism Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Pulmonary Embolism Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Boehringer Ingelheim International Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2016-2021)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2016-2021)
Figure 58. Daiichi Sankyo Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed



• 英文レポート名:Global Pulmonary Embolism Therapeutics Market Size, Status and Forecast 2021-2027
• 日本語訳:肺塞栓症治療薬の世界市場規模・現状・予測(2021-2027)
• レポートコード:QFJ1-5974お問い合わせ(見積依頼・ご注文・質問)